Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
BMLL
BMLL

Bio Medica Laboratories Ltd.

NSE: BMLL
SME
Sector:
Industry Group:
Industry:
148.00+3.0 (+2.03%)
13 Aug, 2:29 PM

Stock Scores

Quality Score

51.9 / 100

Value Score

45.3 / 100

Price Momentum Score

25.2 / 100

QVM Score

28.2 / 100

Key Metrics

Market Cap
182.40
P/E (TTM)
15.34
P/B
6.88
P/S (TTM)
4.23
EV/EBITDA
11.31
CAPE (5Y)
30.91
ROE (TTM)
57.64
ROCE (TTM)
41.05
ROA (TTM)
21.15
Avg 3Y ROE
74.99
Earnings 3Y CAGR
265.51
Sales 3Y CAGR
38.47
Sales 5Y CAGR
27.23
Debt/Equity
1.51
Consensus TP
-
Strong Buy %
-
Promoter Holding
-
Pledged %
-

Share Price

Track Bio Medica Laboratories Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: -1.37 %
Low
144.0
High
157.3
1 Month returns: 6.09 %
Low
130.0
High
162.1
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Bio Medica Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Bio Medica Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Bio Medica Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Bio Medica Laboratories Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Bio Medica Laboratories Ltd.?
The current share price of Bio Medica Laboratories Ltd. is ₹ 148.00 as of 13 Aug 2026.
What is the market capitalisation of Bio Medica Laboratories Ltd.?
The market capitalisation of Bio Medica Laboratories Ltd. stands at ₹ 182.40 Cr.
What is the PE ratio of Bio Medica Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Bio Medica Laboratories Ltd. is 15.34 as of the latest trailing twelve months data.
What is the ROE and ROCE of Bio Medica Laboratories Ltd.?
Bio Medica Laboratories Ltd. has a Return on Equity (ROE) of 57.64% and a Return on Capital Employed (ROCE) of 41.05% as per the latest financial reports.
What is the 52-week high and low of Bio Medica Laboratories Ltd.?
The 52-week high of Bio Medica Laboratories Ltd. is - and the 52-week low is -.
What is the dividend yield of Bio Medica Laboratories Ltd.?
The dividend yield of Bio Medica Laboratories Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Bio Medica Laboratories Ltd.?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Bio Medica Laboratories Ltd. shares.
What sector does Bio Medica Laboratories Ltd. belong to?
Bio Medica Laboratories Ltd. operates in the - sector.
What is the beta of Bio Medica Laboratories Ltd.?
The beta of Bio Medica Laboratories Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Bio Medica Laboratories Ltd.?
The 14-day Relative Strength Index (RSI) of Bio Medica Laboratories Ltd. is 51.10, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.